核酸分离纯化市场按产品类型、技术、样品类型、应用和最终用户划分－2025-2032年全球预测

预计到 2032 年，核酸分离纯化市场规模将达到 161.6 亿美元，复合年增长率为 9.92%。

关键市场统计数据
基准年 2024	75.8亿美元
预计年份：2025年	83.2亿美元
预测年份 2032	161.6亿美元
复合年增长率 (%)	9.92%

介绍核酸分离纯化在研究、诊断和治疗开发平臺中的策略重要性

核酸分离和纯化是许多现代生命科学工作流程的基础，它能够实现可靠的下游分子分析，从而推动发现、诊断和治疗开发。自动化、化学和样品处理技术的进步正在重塑实验室操作，而定序、基于PCR的检测和临床检测的融合则凸显了稳健、可重复萃取平台的重要性。随着实验室优先考虑通量、一致性和污染控制，样品製备步骤中的选择对数据品质和操作效率有显着影响。

本导言从三个营运维度建构了分离纯化流程的宏观框架：技术选择与应用、产品和服务交付模式，以及学术界、临床和工业实验室的终端用户需求。它重点阐述了磁珠化学和自动化工作站等技术创新如何与不断变化的监管预期和实验室规模相互作用。透过阐明术语和应用案例，本节为更深入地探讨变革性转变、关税影响、市场细分洞察、区域动态、公司策略以及为寻求优化产能和提升韧性的相关人员提供的可行建议组装了基础。

深入探讨自动化、磁珠化学和整合工作流程如何重塑核酸萃取实务和实验室预期

由于技术成熟、工作流程整合以及终端用户需求的变化，核酸分离纯化领域正在经历变革。在许多中高通量环境中，自动化已从可选项变为必需品，自动化工作站越来越多地与磁珠化学方法相结合，以提高结果的一致性、减少人工操作时间并实现可扩展的样品处理。磁珠法曾因其灵活性和易于自动化而备受青睐，如今已与柱层析法和过滤法并存，为实验室提供了在速度、纯度和单次样品成本之间进行权衡的频谱。

同时，样本多样性和应用复杂性重塑了产品开发。临床诊断和次世代定序对核酸完整性和抑制剂去除提出了更高的要求，促使供应商优化血液、细胞和组织基质的化学方法。套件和试剂不断发展，以支援标靶定序、转录组学和全基因组应用，仪器製造商也强调模组化设计，以满足不同的通量需求。随着科技的发展，服务模式也在改变。合约研究组织和核心实验室正在提供标准化的提取服务，降低了小型实验室的进入门槛。总而言之，这些趋势表明，提取工具正从单一的解决方案转向整合式、检验的工作流程，以满足可重复性、法规和规模化要求。

对美国于2025年实施的关税如何促使供应链重组、采购转移和库存恢復策略进行全面评估

2025年源自美国的政策转变和贸易行动为全球核酸分离纯化供应链引入了新的变数。关税调整提高了到岸成本和交货的前置作业时间，从而影响了仪器、套件、试剂和耗材的筹资策略。为此，许多实验室和供应商重新评估了其采购计划，重点关注供应商多元化、本地库存缓衝以及区域製造伙伴关係关係，以降低跨境关税波动带来的风险。

关税环境也加速了围绕供应链韧性和成本优化的讨论。采购团队权衡了维持较高国内库存与现金流量影响和仓储需求之间的利弊。同时，一些供应商寻求近岸外包或重组其分销网络，以确保向无法承受中断的临床诊断实验室和受託研究机构提供可靠的供货。监管合规和品管仍然是不可妥协的，这促使企业加大对文件记录和验证方面的投入，以支持替代采购。总体而言，关税促进了策略性供应链重组，凸显了敏捷性、透明度和与供应商的长期合作对于持续获得关键提取产品和服务的重要性。

关键的细分洞察揭示了产品类型、技术、样品矩阵、应用重点和最终用户需求如何影响产品策略和采用。

在核酸分离纯化领域，了解市场区隔对于建立能够满足不同客户需求的、具有针对性的产品策略和商业性模式至关重要。产品类型细分对于实验室采购人员来说非常重要，因为他们可以根据通量和验证要求，在仪器、套件、试剂和服务之间进行选择。仪器包括自动化工作站和纯化仪器，而套件和试剂包括磁珠试剂套件和离心柱试剂套件，它们在操作上各有优劣。诸如柱状分离、过滤、磁珠分离和沈淀等技术，决定了下游检测的兼容性、操作时间和与自动化平台的整合。血液、细胞和组织等样本类型对裂解、抑制剂去除和核酸完整性提出了基质特异性要求，从而推动了化学方法和通讯协定的最佳化。

诊断、基因表现分析、次世代定序和PCR/RT-PCR各自对效能和验证标准有不同的要求。在诊断领域，癌症诊断、遗传疾病检测和感染疾病诊断的需求各不相同，都需要量身定制的工作流程，以平衡灵敏度、特异性和周转时间。次世代定序仪又分为标靶定序、转录组定序和全基因组定序，而输入样本的品质和片段大小会影响萃取方法的选择。最终使用者细分凸显了采​​购週期和应用程式路径的差异。学术研究机构重视灵活性和方法透明度，临床诊断实验室需要严格的验证和持续性，合约研究组织优先考虑通量和可重复性，而製药和生物技术公司则需要可扩展的、符合GMP规范的工作流程。这些相互交织的细分体现在产品蓝图、市场推广策略以及支援不同实验室环境下应用和检验的服务。

深入剖析区域竞争与运营，阐释美洲、欧洲、中东和非洲以及亚太地区如何以独特的方式推动产品应用和供应链优先事项的发展。

在核酸分离纯化领域，区域动态对技术应用、监管协调和供应链设计产生了显着影响。在美洲，成熟的临床诊断基础设施和雄厚的科学研究经费推动了对可与高通量定序和PCR平台整合的、经过验证的提取流程的需求。西欧部分地区强调严格的监管合规性和实验室认证，而该地区的新兴市场则正经历着由不断扩大的临床检测能力和研发投入所驱动的日益增长的需求，因此需要可扩展且经济高效的提取解决方案。在亚太地区，基因组研究的快速发展、临床实验室网络的不断扩展以及蓬勃发展的生物技术产业，推动了对自动化平台和本地化试剂供应的浓厚兴趣，同时也促使人们更加关注支持区域检验和服务覆盖的伙伴关係。

在这些全部区域，报销机制、采购週期和实验室基础设施的差异会影响哪些技术和经营模式能够成功。尤其对于大批量临床检测而言，区域性的生产和分销能力在确保及时获得耗材和设备方面发挥着至关重要的作用。因此，供应商正日益根据区域调整其商业性策略，将本地化的技术支援和检验资源与灵活的物流解决方案相结合，以满足学术中心、临床实验室、合约研究机构 (CRO) 和行业客户的多元化需求。

企业级策略洞察揭示了产品创新、检验的工作流程和服务模式如何重塑竞争定位和商业策略。

核酸分离纯化生态系统中的主要企业正致力于透过产品创新、策略伙伴关係和服务拓展来保障净利率并深化客户关係。许多供应商正投资研发易于自动化操作的化学试剂和模组化仪器设计，从而降低各种规模实验室采用这些技术的门槛。目前，企业策略重点明确放在开发经验证的工作流程上，将萃取性能与下游检测结果连结起来，使供应商能够将产品定位为端到端解决方案，而非仅仅是独立的试剂或仪器。

商业性策略包括加强分销网络、拓展技术支援和培训，以及为临床和研究客户提供特定应用的验证方案。供应商也在探索订阅和耗材付费模式，以稳定需求并提高可预测性。同时，一些公司正在建立或与服务机构合作，提供电子即服务 (eaaS) 解决方案，以解决客户的产能限制并创造差异化的收入来源。试剂配方、仪器自动化演算法和品质系统方面的智慧财产权是竞争优势，有助于在受监管市场中实现高端定位。

为製造商和服务提供者提供切实可行的建议，以加速产品采用、增强韧性并确保长期客户价值。

产业领导者可以采取以下几项切实可行的措施来增强韧性、加速产品普及并提供满足不断变化的实验室需求的产品：在设计仪器和套件时优先考虑与模组化自动化系统的兼容性，使客户能够在不大幅更改实验方案的情况下扩展通讯协定；投资优化磁珠化学以及离心柱和沈淀方案，以确保产品系列满足各种样品和通量需求；加强关键应用（特别是诊断和次世代定序）的技术检验方案，使客户能够受益于更快的部署速度和更清晰的性能预期。

从商业性角度来看，各组织正透过建立多元化的采购管道和区域性分销协议，提升区域供应链的灵活性，以应对关税和物流中断等挑战。拓展附加价值服务，例如方法转移支援、现场培训和萃取即服务，将加深客户参与并创造持续收入。此外，提高品管和监管文件的透明度，有助于推动临床应用，并加快受法规环境下的采购决策。这些措施的结合将使各组织能够掌握由自动化、复杂应用以及对可重复性和合规性日益重视所驱动的需求。

我们透明的调查方法，详细说明了主要研究、次要综合和检验步骤，使我们能够获得可重复和可操作的研究结果。

本报告的研究基于多层次的调查方法，该方法结合了初步的定性研究和严谨的二手分析，并辅以结构化的三角验证，以确保结论的可靠性。初步研究包括对来自学术研究中心、临床诊断实验室、委外研发机构以及製药和生物技术公司的实验室负责人、采购负责人和技术专家的访谈。这些访谈揭示了他们在通量、验证和供应链方面的实际优先事项，检验了从已发表的方案文献和监管指导文件中得出的假设。

二次研究包括对同行评审期刊、行业白皮书、技术应用说明和公开监管文件进行系统性回顾，以梳理技术性能特征和应用适用性。资料综合涉及交叉引用不同来源的观点，识别一致主题，并消除不一致之处。品质保证通讯协定包括多次内部审查、专家检验，并透过记录访谈指南和纳入标准调查方法的透明度。最终的研究成果强调可重复性、对不同终端使用者的适用性以及对评估核酸分离纯化策略的决策者的实际意义。

综合运用技术进步、供应链现况及最终使用者期望等研究成果，为相关人员阐明策略要务。

核酸分离纯化技术融合了创新与实用性，自动化、磁珠化学和整合工作流程正推动其在科研和临床领域的应用。终端用户日益寻求高效、可扩展的解决方案，以缩短週转时间，同时确保核酸完整性，满足次世代定序和高灵敏度诊断检测等高要求下游应用的需求。供应链动态和区域差异进一步影响采购和部署策略，促使供应商和实验室寻求多元化的采购管道和本地支援。

展望未来，将产品开发与模组化自动化、应用特定验证和弹性供应链网路结合的相关人员，将更有能力满足不断变化的实验室需求。对服务产品和区域布局的策略性投资，能够有效补充产品创新，并有助于建立持久的客户伙伴关係和业务连续性。这些结论强调，在这个领域取得成功，可靠的执行和客户支援与技术性能同样重要。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

• 将磁珠技术整合到全自动样品製备平台中，用于高通量诊断
• 在分散式环境下采用微流体晶片系统进行快速照护现场核酸萃取
• 开发常温稳定试剂，以减少现场基因检测工作流程中对低温运输的依赖性
• 推出一款单细胞RNA分离试剂套件，该试剂盒针对超低起始量和高转录组覆盖率进行了优化。
• 扩展直接裂解方法，简化病毒RNA萃取流程，并实现隔日感染疾病监测。
• 在基因组样本纯化流程中应用人工智慧驱动的通讯协定优化技术，以提高产量和纯度
• 扩大基于96孔盘和384孔盘的纯化试剂套件的生产规模，以满足临床实验室应对疫情规模检测的需求
• 将绿色化学方法整合到裂解缓衝液中，以最大限度地减少分子生物学中危险废弃物的产生。
• 为农业中的多重植物病原体检测客製化自动化核酸萃取工作站
• 奈米孔相容萃取方法的进步提高了长读定序在结构变异分析中的品质。

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 依产品类型分類的核酸分离纯化市场

• 装置
  • 自动化工作站
  • 精炼设备
• 套件和试剂
  • 磁珠套件
  • 旋转柱套件
• 服务

第九章 核酸分离纯化市场：依技术划分

• 柱子
• 筛选
• 磁珠
• 沉淀

第十章 依样本类型分類的核酸分离纯化市场

• 血
• 细胞
• 组织

第十一章 核酸分离纯化市场：依应用领域划分

• 诊断
  • 癌症诊断
  • 基因疾病检测
  • 感染疾病诊断
• 基因表现分析
• 次世代定序
  • 标靶定序
  • 转录组定序
  • 全基因组序列分析
• PCR RT-PCR

第十二章 核酸分离纯化市场（依最终用户划分）

• 学术研究机构
• 临床诊断实验室
• 合约研究组织
• 製药和生物技术公司

第十三章 核酸分离纯化市场：依地区划分

• 美洲
  • 北美洲
  • 拉丁美洲
• 欧洲、中东和非洲
  • 欧洲
  • 中东
  • 非洲
• 亚太地区

第十四章 核酸分离纯化市场（依组别划分）

• ASEAN
• GCC
• EU
• BRICS
• G7
• NATO

第十五章 各国核酸分离纯化市场

• 美国
• 加拿大
• 墨西哥
• 巴西
• 英国
• 德国
• 法国
• 俄罗斯
• 义大利
• 西班牙
• 中国
• 印度
• 日本
• 澳洲
• 韩国

第十六章 竞争格局

• 2024年市占率分析
• FPNV定位矩阵，2024
• 竞争分析
  • Agilent Technologies Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Merck KGaA
  • Perkin Elmer Inc.
  • Promega Corporation
  • Takara Bio Inc.
  • Thermo Fisher Scientific Inc.
  • Norgen Biotec Corp.
  • Genaxxon bioscience GmbH
  • Danaher Corporation
  • F. Hoffmann-La Roche Ltd.

The Nucleic Acid Isolation & Purification Market is projected to grow by USD 16.16 billion at a CAGR of 9.92% by 2032.

KEY MARKET STATISTICS
Base Year [2024]	USD 7.58 billion
Estimated Year [2025]	USD 8.32 billion
Forecast Year [2032]	USD 16.16 billion
CAGR (%)	9.92%

Introduction framing the strategic importance of nucleic acid isolation and purification across research, diagnostics, and therapeutic development pipelines

Nucleic acid isolation and purification underpin many contemporary life sciences workflows, enabling reliable downstream molecular analyses that drive discovery, diagnostics, and therapeutic development. Advances in automation, chemistry, and sample processing have reshaped laboratory practices, while the convergence of sequencing, PCR-based assays, and clinical testing has elevated the profile of robust, reproducible extraction platforms. As laboratories prioritize throughput, consistency, and contamination control, the choices made at the sample preparation stage exert outsized influence on data quality and operational efficiency.

This introduction frames the broader landscape by situating isolation and purification processes within three operational axes: technology selection and adoption; product and service delivery models; and end-user needs across academic, clinical, and industry laboratories. It emphasizes how innovations-such as magnetic bead chemistry and automated workstations-interact with regulatory expectations and shifting laboratory footprints. By clarifying terminology and use cases, this section sets the stage for more detailed discussion of transformative shifts, tariff impacts, segmentation insights, regional dynamics, company strategies, and actionable recommendations for stakeholders seeking to optimize capacity and resilience.

Detailed exploration of how automation, magnetic bead chemistry, and integrated workflows are reshaping nucleic acid extraction practices and laboratory expectations

The landscape of nucleic acid isolation and purification has undergone a transformative shift driven by technological maturation, workflow integration, and changing end-user priorities. Automation has moved from optional to essential in many mid-to-high throughput settings, with automated workstations increasingly paired with magnetic bead chemistries to deliver consistency, reduce hands-on time, and enable scalable sample processing. Magnetic bead approaches, favored for flexibility and amenability to automation, now coexist with column and filter methods, offering laboratories a spectrum of trade-offs between speed, purity, and cost per sample.

Concurrently, sample diversity and application complexity have reshaped product development. Clinical diagnostics and next generation sequencing exert high demands for nucleic acid integrity and inhibitor removal, incentivizing suppliers to optimize chemistries for blood, cellular, and tissue matrices. Kits and reagents are evolving to support targeted sequencing, transcriptomics, and whole genome applications, while instrument manufacturers focus on modularity to accommodate diverse throughput needs. Alongside technological evolution, service models have shifted: contract research organizations and core facilities increasingly offer standardized extraction services that lower barriers for smaller labs. Taken together, these trends signal a transition from point-solution extraction tools toward integrated, validated workflows designed to meet reproducibility, regulatory, and scale requirements.

Comprehensive assessment of how United States tariff measures introduced in 2025 catalyzed supply chain reengineering, procurement shifts, and inventory resilience strategies

Policy shifts and trade actions originating in the United States in 2025 introduced new variables into global supply chains that intersect with nucleic acid isolation and purification. Tariff adjustments influenced procurement strategies for instruments, kits, reagents, and consumables by increasing the visibility of landed costs and delivery lead times. In response, many laboratories and suppliers reassessed sourcing plans, placing greater emphasis on supplier diversification, local inventory buffers, and regional manufacturing partnerships to mitigate exposure to cross-border tariff volatility.

The tariff environment also accelerated conversations about supply chain resilience versus cost optimization. Procurement teams weighed the trade-offs inherent in maintaining larger domestic inventories against the cashflow impacts and storage requirements. Meanwhile, some suppliers pursued nearshoring and reconfiguration of distribution networks to preserve delivery reliability to clinical diagnostics laboratories and contract research organizations that cannot tolerate interruptions. Regulatory conformity and quality management remained non-negotiable, prompting investments in documentation and validation to support alternative sourcing. Overall, the tariffs acted as a catalyst for strategic supply chain reengineering and served to highlight the importance of agility, transparency, and long-term supplier collaboration in preserving uninterrupted access to critical extraction products and services.

Key segmentation insights revealing how product type, technology, sample matrix, application focus, and end-user needs converge to shape product strategies and adoption

Understanding segmentation is essential to crafting product strategies and commercial approaches that resonate with diverse customer needs across the nucleic acid isolation and purification space. Product type distinctions matter because laboratory buyers choose between instruments, kits and reagents, and services based on throughput and validation requirements; instruments span automated workstations and purification instruments, while kits and reagents include magnetic bead kits and spin column kits that present different operational trade-offs. Technology segmentation-covering column, filter, magnetic bead, and precipitation methods-shapes downstream assay compatibility, hands-on time, and integration with automation platforms. Sample type considerations such as blood, cells, and tissue impose matrix-specific demands on lysis, inhibitor removal, and nucleic acid integrity, driving the optimization of chemistries and protocols.

Application-driven segmentation further differentiates buyer priorities, with diagnostics, gene expression analysis, next generation sequencing, and PCR/RT-PCR each imposing distinct performance and validation criteria. Within diagnostics, needs diverge across cancer diagnostics, genetic disorder testing, and infectious disease diagnostics, each requiring tailored workflows that balance sensitivity, specificity, and turnaround time. Next generation sequencing splits into targeted sequencing, transcriptome sequencing, and whole genome sequencing, where input quality and fragment size considerations influence extraction choice. End-user segmentation highlights differences in procurement cycles and adoption pathways: academic and research institutes prize flexibility and method transparency; clinical diagnostics laboratories demand stringent validation and continuity; contract research organizations prioritize throughput and reproducibility; and pharmaceutical and biotechnology companies require scalable, GMP-aligned workflows. These intersecting segmentations inform product roadmaps, go-to-market tactics, and services that support adoption and validation across distinct laboratory environments.

Regional competitive and operational insights explaining how the Americas, Europe Middle East & Africa, and Asia-Pacific uniquely drive adoption and supply chain priorities

Regional dynamics exert a pronounced influence on technology adoption, regulatory alignment, and supply chain design across the nucleic acid isolation and purification domain. In the Americas, mature clinical diagnostics infrastructure and robust research funding foster demand for validated extraction workflows that integrate with high-throughput sequencing and PCR platforms; procurement decision-making often prioritizes time-to-result and regulatory conformity. Europe, Middle East & Africa present a heterogeneous landscape: parts of Western Europe emphasize stringent regulatory compliance and laboratory accreditation, while emerging markets within the region exhibit growing demand driven by expanding clinical testing capabilities and research investments, necessitating scalable and cost-effective extraction solutions. In Asia-Pacific, rapid investment in genomic research, expanding clinical testing networks, and a burgeoning biotechnology sector drive strong interest in automated platforms and localized reagent supply, alongside an emphasis on partnerships that support regional validation and service coverage.

Across these regions, differences in reimbursement frameworks, procurement cycles, and laboratory infrastructure influence which technologies and business models succeed. Regional manufacturing and distribution capabilities play an outsized role in ensuring timely access to consumables and instruments, particularly for high-volume clinical testing. As a result, suppliers increasingly tailor commercial approaches by region, combining localized technical support and validation resources with flexible logistics solutions to meet the divergent needs of academic centers, clinical laboratories, CROs, and industry customers.

Strategic company-level insights showing how product innovation, validated workflows, and service models are reshaping competitive positioning and commercial tactics

Leading companies in the nucleic acid isolation and purification ecosystem are pursuing a combination of product innovation, strategic partnerships, and service expansion to protect margins and deepen customer relationships. Many suppliers are investing in automation-compatible chemistries and modular instrument designs that reduce barriers to adoption across laboratories of varying scale. There is a clear strategic emphasis on developing validated workflows that link extraction performance to downstream assay outcomes, enabling vendors to position their offerings as end-to-end solutions rather than isolated reagents or devices.

Commercial tactics include strengthening distribution networks, expanding technical support and training offerings, and providing application-specific validation packages for clinical and research customers. Suppliers are also exploring subscription and consumable-based revenue models to stabilize demand and enhance predictability. In parallel, some companies are building or partnering with service organizations to offer extraction-as-a-service, which addresses capacity constraints for customers and generates differentiated revenue streams. Across these maneuvers, intellectual property in reagent formulations, instrument automation algorithms, and quality systems remains a competitive differentiator that supports premium positioning in regulated markets.

Actionable recommendations that manufacturers and service providers can implement to accelerate adoption, enhance resilience, and secure long-term customer value

Industry leaders can take several practical actions to strengthen resilience, accelerate adoption, and align offerings with evolving laboratory needs. Prioritize modular automation compatibility when designing instruments and kits so that customers can scale throughput without wholesale protocol changes. Invest in magnetic bead chemistry optimization alongside spin column and precipitation options to ensure product portfolios meet a variety of sample and throughput requirements. Strengthen technical validation packages for key applications-particularly diagnostics and next generation sequencing-so customers benefit from reduced implementation time and clearer performance expectations.

From a commercial perspective, cultivate regional supply chain flexibility by establishing multiple sourcing options and localized distribution agreements to guard against tariff and logistics disruptions. Expand value-added services such as method transfer support, on-site training, and extraction-as-a-service offerings to deepen customer engagement and create recurring revenue. Finally, enhance transparency around quality management and regulatory documentation to support clinical adoption and accelerate procurement decisions in regulated environments. These combined actions will help organizations capture demand driven by automation, complex applications, and an increased emphasis on reproducibility and regulatory compliance.

Transparent research methodology detailing primary engagement, secondary synthesis, and validation steps used to ensure reproducible and actionable insights

The research underpinning this report relied on a multilayered methodological approach combining primary qualitative engagement and rigorous secondary analysis, supplemented by structured triangulation to ensure robust conclusions. Primary research included interviews with laboratory leaders, procurement officers, and technical specialists across academic research centers, clinical diagnostics laboratories, contract research organizations, and pharmaceutical and biotechnology companies. These conversations illuminated real-world priorities around throughput, validation, and supply chain concerns, and served to validate assumptions drawn from published protocol literature and regulatory guidance documents.

Secondary research encompassed a systematic review of peer-reviewed journals, industry white papers, technical application notes, and public regulatory filings to map technology performance characteristics and application suitability. Data synthesis involved cross-referencing insights across sources to identify convergent themes and reconcile discrepancies. Quality assurance protocols included multiple rounds of internal review, expert validation, and methodological transparency with documented interview guides and inclusion criteria. The result is a research foundation that emphasizes reproducibility, applicability to diverse end-users, and practical relevance for decision-makers evaluating nucleic acid isolation and purification strategies.

Concluding synthesis that integrates technological advances, supply chain realities, and end-user expectations to clarify strategic imperatives for stakeholders

The conclusion synthesizes the principal themes: nucleic acid isolation and purification are at the intersection of technological innovation and operational pragmatism, where automation, magnetic bead chemistry, and integrated workflows drive adoption across research and clinical settings. End-users increasingly demand validated, scalable solutions that reduce hands-on time while safeguarding nucleic acid integrity for demanding downstream applications such as next generation sequencing and sensitive diagnostic assays. Supply chain dynamics and regional variations further influence procurement and deployment strategies, encouraging suppliers and laboratories to pursue diversified sourcing and localized support structures.

Looking forward, stakeholders who align product development with modular automation, application-specific validation, and resilient supply networks will be best positioned to meet evolving laboratory requirements. Strategic investments in service offerings and regional presence will complement product innovation, enabling sustained customer partnerships and operational continuity. These conclusions underscore that success in this domain is as much about dependable execution and customer support as it is about technical performance.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Integration of magnetic bead technology in fully automated sample preparation platforms for high-throughput diagnostics
• 5.2. Adoption of microfluidic chip systems enabling rapid point-of-care nucleic acid extraction in decentralized settings
• 5.3. Development of ambient temperature stable reagents reducing cold chain dependency for field-based genetic testing workflows
• 5.4. Emergence of single-cell RNA isolation kits optimized for ultra-low input and high transcriptome coverage
• 5.5. Expansion of direct lysis methodologies streamlining viral RNA extraction for next-day infectious disease surveillance
• 5.6. Implementation of AI-driven protocol optimizations improving yield and purity in genomic sample purification pipelines
• 5.7. Scale-up of 96- and 384-well plate-based purification kits supporting pandemic-scale testing demands in clinical labs
• 5.8. Integration of green chemistry approaches in lysis buffers minimizing hazardous waste generation in molecular biology
• 5.9. Customization of automated nucleic acid extraction workstations for multiplexed plant pathogen detection in agriculture
• 5.10. Advancements in nanopore-friendly extraction methods enhancing long-read sequencing quality for structural variant analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Nucleic Acid Isolation & Purification Market, by Product Type

• 8.1. Instruments
  • 8.1.1. Automated Workstations
  • 8.1.2. Purification Instruments
• 8.2. Kits & Reagents
  • 8.2.1. Magnetic Bead Kits
  • 8.2.2. Spin Column Kits
• 8.3. Services

9. Nucleic Acid Isolation & Purification Market, by Technology

• 9.1. Column
• 9.2. Filter
• 9.3. Magnetic Bead
• 9.4. Precipitation

10. Nucleic Acid Isolation & Purification Market, by Sample Type

• 10.1. Blood
• 10.2. Cells
• 10.3. Tissue

11. Nucleic Acid Isolation & Purification Market, by Application

• 11.1. Diagnostics
  • 11.1.1. Cancer Diagnostics
  • 11.1.2. Genetic Disorder Testing
  • 11.1.3. Infectious Disease Diagnostics
• 11.2. Gene Expression Analysis
• 11.3. Next Generation Sequencing
  • 11.3.1. Targeted Sequencing
  • 11.3.2. Transcriptome Sequencing
  • 11.3.3. Whole Genome Sequencing
• 11.4. PCR RT-PCR

12. Nucleic Acid Isolation & Purification Market, by End User

• 12.1. Academic & Research Institutes
• 12.2. Clinical Diagnostics Laboratories
• 12.3. Contract Research Organizations
• 12.4. Pharmaceutical & Biotechnology Companies

13. Nucleic Acid Isolation & Purification Market, by Region

• 13.1. Americas
  • 13.1.1. North America
  • 13.1.2. Latin America
• 13.2. Europe, Middle East & Africa
  • 13.2.1. Europe
  • 13.2.2. Middle East
  • 13.2.3. Africa
• 13.3. Asia-Pacific

14. Nucleic Acid Isolation & Purification Market, by Group

• 14.1. ASEAN
• 14.2. GCC
• 14.3. European Union
• 14.4. BRICS
• 14.5. G7
• 14.6. NATO

15. Nucleic Acid Isolation & Purification Market, by Country

• 15.1. United States
• 15.2. Canada
• 15.3. Mexico
• 15.4. Brazil
• 15.5. United Kingdom
• 15.6. Germany
• 15.7. France
• 15.8. Russia
• 15.9. Italy
• 15.10. Spain
• 15.11. China
• 15.12. India
• 15.13. Japan
• 15.14. Australia
• 15.15. South Korea

16. Competitive Landscape

• 16.1. Market Share Analysis, 2024
• 16.2. FPNV Positioning Matrix, 2024
• 16.3. Competitive Analysis
  • 16.3.1. Agilent Technologies Inc.
  • 16.3.2. Becton, Dickinson and Company
  • 16.3.3. Bio-Rad Laboratories, Inc.
  • 16.3.4. Merck KGaA
  • 16.3.5. Perkin Elmer Inc.
  • 16.3.6. Promega Corporation
  • 16.3.7. Takara Bio Inc.
  • 16.3.8. Thermo Fisher Scientific Inc.
  • 16.3.9. Norgen Biotec Corp.
  • 16.3.10. Genaxxon bioscience GmbH
  • 16.3.11. Danaher Corporation
  • 16.3.12. F. Hoffmann-La Roche Ltd.

LIST OF FIGURES

• FIGURE 1. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, 2018-2032 (USD MILLION)
• FIGURE 2. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
• FIGURE 3. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 4. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
• FIGURE 5. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 6. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2032 (%)
• FIGURE 7. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 8. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
• FIGURE 9. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 10. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY END USER, 2024 VS 2032 (%)
• FIGURE 11. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 12. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 13. AMERICAS NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 14. NORTH AMERICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 15. LATIN AMERICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 16. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 17. EUROPE NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 18. MIDDLE EAST NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 19. AFRICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 20. ASIA-PACIFIC NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 21. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 22. ASEAN NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 23. GCC NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 24. EUROPEAN UNION NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 25. BRICS NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 26. G7 NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 27. NATO NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 28. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 29. NUCLEIC ACID ISOLATION & PURIFICATION MARKET SHARE, BY KEY PLAYER, 2024
• FIGURE 30. NUCLEIC ACID ISOLATION & PURIFICATION MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

• TABLE 1. NUCLEIC ACID ISOLATION & PURIFICATION MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
• TABLE 3. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, 2018-2024 (USD MILLION)
• TABLE 4. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, 2025-2032 (USD MILLION)
• TABLE 5. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 6. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
• TABLE 7. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
• TABLE 8. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
• TABLE 9. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 10. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY INSTRUMENTS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 11. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 12. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 13. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 14. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 15. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY AUTOMATED WORKSTATIONS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 16. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY AUTOMATED WORKSTATIONS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 17. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY AUTOMATED WORKSTATIONS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 18. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY AUTOMATED WORKSTATIONS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 19. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY AUTOMATED WORKSTATIONS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 20. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY AUTOMATED WORKSTATIONS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 21. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PURIFICATION INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 22. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PURIFICATION INSTRUMENTS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 23. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PURIFICATION INSTRUMENTS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 24. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PURIFICATION INSTRUMENTS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 25. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PURIFICATION INSTRUMENTS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 26. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PURIFICATION INSTRUMENTS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 27. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY KITS & REAGENTS, 2018-2024 (USD MILLION)
• TABLE 28. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY KITS & REAGENTS, 2025-2032 (USD MILLION)
• TABLE 29. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY KITS & REAGENTS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 30. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY KITS & REAGENTS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 31. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY KITS & REAGENTS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 32. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY KITS & REAGENTS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 33. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY KITS & REAGENTS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 34. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY KITS & REAGENTS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 35. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY MAGNETIC BEAD KITS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 36. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY MAGNETIC BEAD KITS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 37. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY MAGNETIC BEAD KITS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 38. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY MAGNETIC BEAD KITS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 39. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY MAGNETIC BEAD KITS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 40. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY MAGNETIC BEAD KITS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 41. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY SPIN COLUMN KITS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 42. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY SPIN COLUMN KITS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 43. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY SPIN COLUMN KITS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 44. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY SPIN COLUMN KITS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 45. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY SPIN COLUMN KITS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 46. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY SPIN COLUMN KITS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 47. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY SERVICES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 48. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY SERVICES, BY REGION, 2025-2032 (USD MILLION)
• TABLE 49. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY SERVICES, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 50. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY SERVICES, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 51. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY SERVICES, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 52. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY SERVICES, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 53. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 54. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
• TABLE 55. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY COLUMN, BY REGION, 2018-2024 (USD MILLION)
• TABLE 56. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY COLUMN, BY REGION, 2025-2032 (USD MILLION)
• TABLE 57. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY COLUMN, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 58. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY COLUMN, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 59. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY COLUMN, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 60. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY COLUMN, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 61. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY FILTER, BY REGION, 2018-2024 (USD MILLION)
• TABLE 62. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY FILTER, BY REGION, 2025-2032 (USD MILLION)
• TABLE 63. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY FILTER, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 64. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY FILTER, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 65. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY FILTER, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 66. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY FILTER, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 67. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY MAGNETIC BEAD, BY REGION, 2018-2024 (USD MILLION)
• TABLE 68. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY MAGNETIC BEAD, BY REGION, 2025-2032 (USD MILLION)
• TABLE 69. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY MAGNETIC BEAD, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 70. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY MAGNETIC BEAD, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 71. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY MAGNETIC BEAD, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 72. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY MAGNETIC BEAD, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 73. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PRECIPITATION, BY REGION, 2018-2024 (USD MILLION)
• TABLE 74. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PRECIPITATION, BY REGION, 2025-2032 (USD MILLION)
• TABLE 75. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PRECIPITATION, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 76. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PRECIPITATION, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 77. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PRECIPITATION, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 78. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PRECIPITATION, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 79. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
• TABLE 80. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY SAMPLE TYPE, 2025-2032 (USD MILLION)
• TABLE 81. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY BLOOD, BY REGION, 2018-2024 (USD MILLION)
• TABLE 82. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY BLOOD, BY REGION, 2025-2032 (USD MILLION)
• TABLE 83. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY BLOOD, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 84. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY BLOOD, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 85. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY BLOOD, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 86. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY BLOOD, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 87. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY CELLS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 88. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY CELLS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 89. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY CELLS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 90. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY CELLS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 91. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY CELLS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 92. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY CELLS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 93. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY TISSUE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 94. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY TISSUE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 95. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY TISSUE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 96. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY TISSUE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 97. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY TISSUE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 98. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY TISSUE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 99. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 100. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 101. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
• TABLE 102. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY DIAGNOSTICS, 2025-2032 (USD MILLION)
• TABLE 103. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 104. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 105. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY DIAGNOSTICS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 106. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY DIAGNOSTICS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 107. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY DIAGNOSTICS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 108. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY DIAGNOSTICS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 109. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY CANCER DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 110. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY CANCER DIAGNOSTICS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 111. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY CANCER DIAGNOSTICS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 112. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY CANCER DIAGNOSTICS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 113. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY CANCER DIAGNOSTICS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 114. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY CANCER DIAGNOSTICS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 115. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY GENETIC DISORDER TESTING, BY REGION, 2018-2024 (USD MILLION)
• TABLE 116. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY GENETIC DISORDER TESTING, BY REGION, 2025-2032 (USD MILLION)
• TABLE 117. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY GENETIC DISORDER TESTING, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 118. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY GENETIC DISORDER TESTING, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 119. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY GENETIC DISORDER TESTING, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 120. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY GENETIC DISORDER TESTING, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 121. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 122. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSTICS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 123. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSTICS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 124. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSTICS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 125. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSTICS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 126. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSTICS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 127. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY GENE EXPRESSION ANALYSIS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 128. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY GENE EXPRESSION ANALYSIS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 129. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY GENE EXPRESSION ANALYSIS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 130. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY GENE EXPRESSION ANALYSIS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 131. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY GENE EXPRESSION ANALYSIS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 132. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY GENE EXPRESSION ANALYSIS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 133. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
• TABLE 134. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2032 (USD MILLION)
• TABLE 135. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
• TABLE 136. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2025-2032 (USD MILLION)
• TABLE 137. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 138. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 139. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 140. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 141. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY TARGETED SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
• TABLE 142. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY TARGETED SEQUENCING, BY REGION, 2025-2032 (USD MILLION)
• TABLE 143. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY TARGETED SEQUENCING, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 144. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY TARGETED SEQUENCING, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 145. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY TARGETED SEQUENCING, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 146. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY TARGETED SEQUENCING, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 147. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY TRANSCRIPTOME SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
• TABLE 148. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY TRANSCRIPTOME SEQUENCING, BY REGION, 2025-2032 (USD MILLION)
• TABLE 149. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY TRANSCRIPTOME SEQUENCING, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 150. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY TRANSCRIPTOME SEQUENCING, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 151. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY TRANSCRIPTOME SEQUENCING, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 152. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY TRANSCRIPTOME SEQUENCING, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 153. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
• TABLE 154. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY REGION, 2025-2032 (USD MILLION)
• TABLE 155. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 156. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 157. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 158. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 159. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PCR RT-PCR, BY REGION, 2018-2024 (USD MILLION)
• TABLE 160. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PCR RT-PCR, BY REGION, 2025-2032 (USD MILLION)
• TABLE 161. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PCR RT-PCR, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 162. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PCR RT-PCR, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 163. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PCR RT-PCR, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 164. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PCR RT-PCR, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 165. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 166. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 167. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 168. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2025-2032 (USD MILLION)
• TABLE 169. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 170. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 171. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 172. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 173. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY CLINICAL DIAGNOSTICS LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 174. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY CLINICAL DIAGNOSTICS LABORATORIES, BY REGION, 2025-2032 (USD MILLION)
• TABLE 175. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY CLINICAL DIAGNOSTICS LABORATORIES, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 176. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY CLINICAL DIAGNOSTICS LABORATORIES, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 177. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY CLINICAL DIAGNOSTICS LABORATORIES, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 178. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY CLINICAL DIAGNOSTICS LABORATORIES, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 179. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 180. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 181. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 182. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 183. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 184. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 185. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 186. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2025-2032 (USD MILLION)
• TABLE 187. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 188. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 189. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 190. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 191. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 192. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 193. AMERICAS NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
• TABLE 194. AMERICAS NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
• TABLE 195. AMERICAS NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 196. AMERICAS NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
• TABLE 197. AMERICAS NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
• TABLE 198. AMERICAS NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
• TABLE 199. AMERICAS NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY KITS & REAGENTS, 2018-2024 (USD MILLION)
• TABLE 200. AMERICAS NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY KITS & REAGENTS, 2025-2032 (USD MILLION)
• TABLE 201. AMERICAS NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 202. AMERICAS NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
• TABLE 203. AMERICAS NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
• TABLE 204. AMERICAS NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY SAMPLE TYPE, 2025-2032 (USD MILLION)
• TABLE 205. AMERICAS NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 206. AMERICAS NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 207. AMERICAS NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
• TABLE 208. AMERICAS NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY DIAGNOSTICS, 2025-2032 (USD MILLION)
• TABLE 209. AMERICAS NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
• TABLE 210. AMERICAS NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2032 (USD MILLION)
• TABLE 211. AMERICAS NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 212. AMERICAS NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 213. NORTH AMERICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 214. NORTH AMERICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 215. NORTH AMERICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 216. NORTH AMERICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
• TABLE 217. NORTH AMERICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
• TABLE 218. NORTH AMERICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
• TABLE 219. NORTH AMERICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY KITS & REAGENTS, 2018-2024 (USD MILLION)
• TABLE 220. NORTH AMERICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY KITS & REAGENTS, 2025-2032 (USD MILLION)
• TABLE 221. NORTH AMERICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 222. NORTH AMERICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
• TABLE 223. NORTH AMERICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
• TABLE 224. NORTH AMERICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY SAMPLE TYPE, 2025-2032 (USD MILLION)
• TABLE 225. NORTH AMERICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 226. NORTH AMERICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 227. NORTH AMERICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
• TABLE 228. NORTH AMERICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY DIAGNOSTICS, 2025-2032 (USD MILLION)
• TABLE 229. NORTH AMERICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
• TABLE 230. NORTH AMERICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2032 (USD MILLION)
• TABLE 231. NORTH AMERICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 232. NORTH AMERICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 233. LATIN AMERICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 234. LATIN AMERICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 235. LATIN AMERICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 236. LATIN AMERICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
• TABLE 237. LATIN AMERICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
• TABLE 238. LATIN AMERICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
• TABLE 239. LATIN AMERICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY KITS & REAGENTS, 2018-2024 (USD MILLION)
• TABLE 240. LATIN AMERICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY KITS & REAGENTS, 2025-2032 (USD MILLION)
• TABLE 241. LATIN AMERICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 242. LATIN AMERICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
• TABLE 243. LATIN AMERICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
• TABLE 244. LATIN AMERICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY SAMPLE TYPE, 2025-2032 (USD MILLION)
• TABLE 245. LATIN AMERICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 246. LATIN AMERICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 247. LATIN AMERICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
• TABLE 248. LATIN AMERICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY DIAGNOSTICS, 2025-2032 (USD MILLION)
• TABLE 249. LATIN AMERICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
• TABLE 250. LATIN AMERICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2032 (USD MILLION)
• TABLE 251. LATIN AMERICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 252. LATIN AMERICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 253. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
• TABLE 254. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
• TABLE 255. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 256. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
• TABLE 257. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
• TABLE 258. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
• TABLE 259. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY KITS & REAGENTS, 2018-2024 (USD MILLION)
• TABLE 260. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY KITS & REAGENTS, 2025-2032 (USD MILLION)
• TABLE 261. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 262. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
• TABLE 263. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
• TABLE 264. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY SAMPLE TYPE, 2025-2032 (USD MILLION)
• TABLE 265. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 266. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 267. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID ISOLATION & PURIFICATION MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
• TABLE 268. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID ISOLATION &